Magnus Financial Group’s Altimmune ALT Stock Holding History

Magnus Financial Group’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,000	Closed	-$50K	–	384
2025 Q1	$50K	Buy	+10,000	New	+$63.3K	﹤0.01%	362

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnus Financial Group's ALT Position: Q2 2025 in Review

Magnus Financial Group sold out of Altimmune (ALT) in Q2 2025, closing a stake of 10,000 shares — an estimated $50K sold.

Magnus Financial Group first reported a position in ALT in Q1 2025 and held it in 1 quarter. The position peaked at $50K in Q1 2025. 180 funds tracked by Wall St. Rank hold ALT as of Q2 2025.

Magnus Financial Group reported no remaining Altimmune position as of Q2 2025 after selling out during the quarter.
Magnus Financial Group sold 10,000 Altimmune shares in Q2 2025, an estimated $50K.
Magnus Financial Group first reported a position in Altimmune in Q1 2025 and held it in 1 quarter.
Magnus Financial Group's Altimmune position peaked at $50K in Q1 2025.
180 funds tracked by Wall St. Rank held Altimmune as of Q2 2025.

Based on Magnus Financial Group's 13F filing for Q2 2025, filed 16 Jul 2025.